You are here: Industry Insights > Genzyme

News List

Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets expresspharma
June 18, 2021
They are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis.
Use of Genzyme's MS drug Lemtrada restricted under ongoing EMA safety review pharmafile
April 17, 2019
The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety issues arising from heart
Sanofi blueprints hefty new Boston HQ with massive lease at Cambridge Crossing fiercepharma
December 26, 2018
Sanofi has picked the spot for its Massachusetts headquarters, once again planting its flag squarely in the Kendall Square neighborhood that's the epicenter of biotech on the East Coast.
Thanks to Genzyme—and no thanks to vaccines or diabetes—Sanofi is treading water fiercepharma
August 01, 2018
As much as Sanofi has struggled with diabetes and generic drugs the past few years, it could typically count on vaccines and Genzyme to come to the rescue. This quarter, Genzyme played its usual lifeguard role, but vaccines fell down on the job.
Voyager Therapeutics poaches Genzyme, Sanofi executive Andre Turenne as new CEO fiercebiotech
July 09, 2018
Four months after Voyager Therapeutics’ chief and founder Steven Paul, M.D., said he would step down to become an “executive science adviser,” the neurological disease biotech has found a new leader.
Sanofi's fourth-quarter profit more than doubles; Genzyme sales jump firstwordpharma
February 09, 2017
Sanofi announced Wednesday that fourth-quarter net income more than doubled versus the prior year to 790 million euros ($841 million), while sales increased 3.3 percent to 8.9 billion euros ($9.5 billion), meeting analyst estimates.